Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 13 , ISSUE 4 ( October-December, 2024 ) > List of Articles

SHORT COMMUNICATION

Promoting Universal Access to Tuberculosis through a Five-pronged Strategy: World Health Organization

Saurabh RamBihariLal Shrivastava, Prateek Sudhakar Bobhate

Keywords : Access, Tuberculosis, World Health Organization

Citation Information : Shrivastava SR, Bobhate PS. Promoting Universal Access to Tuberculosis through a Five-pronged Strategy: World Health Organization. Indian J Respir Care 2024; 13 (4):268-269.

DOI: 10.5005/jp-journals-11010-1137

License: CC BY-NC 4.0

Published Online: 17-02-2025

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Tuberculosis (TB) continues to be regarded as one of the leading diseases of infectious origin, accounting for the maximum number of deaths. Even though, owing to consistent and concerted efforts, we have made progress in terms of saving the lives of affected individuals and ensuring access to treatment, we are still off track in meeting our targets to end the disease epidemic by the year 2030. To interrupt the present trajectory of TB, there is an immense need to ensure access to disease-related prevention and care services, promote research and development, and introduce innovations. In the proposed initiative, five specific strategies—namely Engage, Accelerate, Align, Account, and Advocacy—have been proposed. In conclusion, in the battle against one of the deadliest infectious diseases, it is extremely crucial that no one must be left behind in equitably accessing prevention and care-related services. The proposed initiative is an attempt to intensify the ongoing efforts and thereby ensure that we take appropriate measures to be on the right track to attain the set targets by 2030.


PDF Share
  1. World Health Organization. Tuberculosis – Key Facts; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis [Last accessed on 2024 Mar 1].
  2. World Health Organization. WHO Director-General flagship initiative to #ENDTB Universal access to TB prevention and care: Towards Universal Health Coverage (UHC) 2023-2027. Geneva: WHO press; 2023. pp: 1–14.
  3. Thakur G, Thakur S, Thakur H. Status and challenges for tuberculosis control in India - Stakeholders’ perspective. Indian J Tuberc 2021;68:334–339. DOI: 10.1016/j.ijtb.2020.10.001
  4. Kielmann K, Karat AS, Zwama G, et al. Tuberculosis infection prevention and control: why we need a whole systems approach. Infect Dis Poverty 2020;9:56. DOI: 10.1186/s40249-020-00667-6
  5. Arcêncio RA, Chimara E, Silva JRLE, et al. Research, innovation, and national production of strategic inputs for tuberculosis elimination in Brazil: Contributions from the REDE-TB. Rev Soc Bras Med Trop 2023;56:e0518. DOI: 10.1590/0037-8682-0518-2023
  6. Baker JA. Respiratory therapist-driven protocol in primary care: is the profession ready and able to expand into primary care? Respir Care 2023;68:1320–1321. DOI: 10.4187/respcare.11330
  7. M Burnett D, R Sharpe M. Identifying the role of the respiratory therapist on the multidisciplinary team in the intensive care recovery clinic. Respir Care 2021;66:1929–1931. DOI: 10.4187/respcare.09644
  8. Vyawahare CR, Ratnaparkhi MM, Athavale PV, et al. Leveraging nutritional interventions: a silver bullet to aid in the management of tuberculosis. Indian J Respir Care 2024;13:217–218. DOI: 10.5005/jp-journals-11010-1127
  9. Kunst H. Cross-border collaboration in tuberculosis prevention and care in Europe: can we do better? Int J Tuberc Lung Dis 2017;21:717. DOI: 10.5588/ijtld.17.0283
  10. Saluzzo F, Espinosa-Pereiro J, Dressler S, et al. Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience. Int J Infect Dis 2023;130:S20–S24. DOI: 10.1016/j.ijid.2023.03.008
  11. Juliasih NN, Soedarsono, Sari RM. Analysis of tuberculosis program management in primary health care. Infect Dis Rep 2020;12:8728. DOI: 10.4081/idr.2020.8728
  12. García-Basteiro AL, Ruhwald M, Lange C. Design of tuberculosis vaccine trials under financial constraints. Expert Rev Vaccines 2016;15:799–801. DOI: 10.1080/14760584.2016.1178067
  13. Visca D, Ong CWM, Tiberi S, et al. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology 2021;27:151–165. DOI: 10.1016/j.pulmoe.2020.12.012
  14. Rakesh PS, Balakrishnan S, Mrithunjayan S, et al. Decentralized tuberculosis surveillance for advocacy, local planning, and action: a case study from Kerala, India. Indian J Community Med 2022;47:149–150. DOI: 10.4103/ijcm.ijcm_583_21
  15. Mahmud S, Mohsin M, Irfan SH, et al. Knowledge, attitude, practices, and determinants of them toward tuberculosis among social media users in Bangladesh: a cross-sectional study. PLoS One 2022;17:e0275344. DOI: 10.1371/journal.pone.0275344
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.